Walden Group Navigation
  • About Us
    • Overview
    • Corporate Sales & Divestures
    • Acquisition Searches
    • Strategic Consulting
  • Completed Transactions
  • Sectors Covered
  • Testimonials
  • Key People
  • Blog
  • Contact Us
  • About Us
    • Overview
    • Corporate Sales & Divestures
    • Acquisition Searches
    • Strategic Consulting
  • Completed Transactions
  • Sectors Covered
  • Testimonials
  • Key People
  • Blog
  • Contact Us
Home Blog Zimmer Biomet Acquires Embody for $150m
Strategic Healthcare Mergers and Acquisitions (M&A)
  • (914) 332-9700
  • Email Us
Strategic Health M&A Report
  • About Us
    • Overview
    • Corporate Sales & Divestures
    • Acquisition Searches
    • Strategic Consulting
  • Completed Transactions
  • Sectors Covered
  • Testimonials
  • Key People
  • Blog
  • Contact Us

Zimmer Biomet Acquires Embody for $150m

1/9/2023

Zimmer Biomet Holdings, Inc., a $8.0b maker of orthopedic reconstructive products is acquiring Embody, Inc., a developer of collagen implants for repairing tendons, ligaments and torn rotator cuffs.  The acquisition builds Zimmer Biomet’s sports medicine offerings after it spun-off its dental and spine operations into Zimvie, a separate, publicly-traded company in March 2022.  Deal value - $155m plus $120m in milestones.


Back To Blog

Search By Keyword

Recent blog posts

  • Zimmer Biomet Acquires Embody for $150m
  • The Walden Group Represented Total Titanium, Inc in Its Sale to a Subsidiary of Bausch + Lomb Corporation
  • The Walden Group Releases Q3 2022 Strategic Healthcare M&A Report
  • Aspen Surgical Acquires Symmetry Surgical
  • Halma Purchases IZI Medical Products for $153.5m
  • CVS Acquires Signify Health for $8b
  • Teleflex Acquires Standard Bariatrics for $170m
  • Patient Square Capital to Acquire Hanger for $1.2b
  • BD (Becton, Dickinson and Company) Completes $1.5b Acquisition of Parata Systems
  • OrthoPediatrics to Acquire Pega Medical
  • Biosynth Carbosynth Acquires Aalto Bio Reagents
  • The Walden Group Releases Q1 2022 Strategic Healthcare M&A Report
  • The Walden Group was Engaged by Katalyst Surgical, LLC and Initiated Its Merger with Carl Zeiss Meditec AG
  • Integer Acquires Aran Biomedical
  • Teamvantage Acquires MMD Medical

The Walden Group | (914) 332-9700 | office@waldenmed.com

Tarrytown Corporate Center, 560 White Plains Rd.

Tarrytown, New York 10591

  • About Us
  • Completed Transactions
  • Sectors Covered
  • Testimonials
  • Key People
  • Blog
  • Contact Us

©2023 The Walden Group | All Rights Reserved

Toggle the Widgetbar